Trial Profile
A randomised controlled trial of 225 versus 300 IU recombinant follicle stimulating hormone (FSH) for ovarian stimulation in predicted normal responders by antral follicle count.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 29 Mar 2010 Primary endpoint 'Number of oocytes' has not been met.
- 29 Mar 2010 Results published in BJOG: An International Journal of Obstetrics and Gynaecology.
- 01 Dec 2008 New trial record.